Literature DB >> 29488430

Endoscopic management of refractory gastroesophageal reflux disease.

Waseem M Seleem1, Amr Shaaban Hanafy1, Samir I Mohamed2.   

Abstract

OBJECTIVE: Despite the therapeutic and surgical interventions for the management of gastroesophageal reflux disease (GERD), yet the high cost and the post-operative complications had led to a significant socioeconomic burden. The aim was to evaluate the safety and efficacy of endoscopic band ligation (EBL) in the management of refractory GERD.
METHODS: A total of 150 patients with refractory GERD were assigned to an EBL group (banding was done at four quadrants just at the gastroesophageal junction (GEJ) (n = 75) or to a control group (optimized dose of PPI, n = 75). Follow-up for both groups by upper GI endoscopy to evaluate the site of the Z line from the incisors, the width of the GEJ and the coaptation of GEJ around the endoscope on retroflection. PH monitoring was performed every 3 months with GERD- QoL assessment monthly for 1 year.
RESULTS: In EBL group; 58 patients (77.3%) needed 1 session, 17 patients (22.7%) needed 2 sessions. 4 rubber bands were utilized in 44 patients (58.7%), 3 rubber bands in 31 patients (41.3%). Follow-up for 1 year revealed a highly significant improvement of the GERD- QoL score, the site of Z line with significant reduction of reflux episodes and symptom index when compared to the medical treatment group. In EBL group; there were no major adverse events including bleeding, post band ulcers, stenosis at one year follow up.
CONCLUSION: The current study provides a novel endoscopic intervention to treat refractory GERD, which is safe, cost-effective, with no major adverse effects at one year follow up.

Entities:  

Keywords:  GERD; Refractory; endoscopic treatment

Mesh:

Substances:

Year:  2018        PMID: 29488430     DOI: 10.1080/00365521.2018.1445775

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.

Authors:  In Kyung Yoo; Weon Jin Ko; Hak Su Kim; Hee Kyung Kim; Jung Hyun Kim; Won Hee Kim; Sung Pyo Hong; Abdullah Özgür Yeniova; Joo Young Cho
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

2.  Update on Endoscopic Approaches for the Management of Gastroesophageal Reflux Disease.

Authors:  Zaheer Nabi; D Nageshwar Reddy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-07

Review 3.  Antireflux mucosal intervention (ARMI) procedures for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Jen-Hao Yeh; Ching-Tai Lee; Min-Hung Hsu; Chi-Wen Lin; Po-Jen Hsiao; Chien-Lin Chen; Wen-Lun Wang
Journal:  Therap Adv Gastroenterol       Date:  2022-04-29       Impact factor: 4.802

Review 4.  Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors.

Authors:  Fahmi Shibli; Yoshitaka Kitayama; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

Review 5.  Endoscopic anti-reflux therapy for gastroesophageal reflux disease.

Authors:  Enrique Rodríguez de Santiago; Eduardo Albéniz; Fermin Estremera-Arevalo; Carlos Teruel Sanchez-Vegazo; Vicente Lorenzo-Zúñiga
Journal:  World J Gastroenterol       Date:  2021-10-21       Impact factor: 5.742

Review 6.  Advanced Endoscopic Imaging and Interventions in GERD: An Update and Future Directions.

Authors:  Rupinder Mann; Mahesh Gajendran; Abhilash Perisetti; Hemant Goyal; Shreyas Saligram; Chandraprakash Umapathy
Journal:  Front Med (Lausanne)       Date:  2021-11-29

Review 7.  The role of endoscopy in the management of gastroesophageal reflux disease.

Authors:  Shiko Kuribayashi; Hiroko Hosaka; Fumihiko Nakamura; Ko Nakata; Keigo Sato; Yuki Itoi; Yu Hashimoto; Kengo Kasuga; Hirohito Tanaka; Toshio Uraoka
Journal:  DEN open       Date:  2021-12-30

8.  Study on the Effect of Different Endoscopic Auxiliary Treatment of Gastric Mucosal Microtumor.

Authors:  Xiongping Zhong; Fuqun Wang; Dehui Zeng; Yijin Chen; Shengbing Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-11       Impact factor: 2.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.